Beneficial effect of integrated nutritional interventions in patients with hematological diseases undergoing hematopoietic stem cell transplant

2024-9-12

Outcomes of Fedratinib in routine Treatment of ruxolitinib-resistant or refractory patients with Primary and post-polycythemia vera or essential thrombocythemia Myelofibrosis: A nationalwide retrospective study.

2024-9-12

r/r LBCL: CAR-T-Zelltherapie im Behandlungsalltag

2024-9-10

Prognostic value of the pretransplant fibrosis-4 (FIB-4) index on nonrelapse and overall mortality following unrelated single-unit cord blood transplantation in adults

2024-8-28

Real-world impact of routine addition of anti-thymocyte globulin to standard GVHD prophylaxis in myeloablative unrelated donor transplants: important gains in graft vs host disease prevention though no difference in overall survival

2024-8-28

Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation

2024-8-27

Disseminated Mucormycosis and T-Cell-Depleted Allogeneic Stem Cell Transplantation: An Unusual Case Study

2024-8-21

The Latin American experience in POEMS syndrome. A study of the GELAMM (Grupo de Estudios Latinoamericanos de Mieloma Múltiple)

2024-8-10

A Case of Recurrent Localized Pulmonary Nodular Light Chain Amyloidosis Treated with Daratumumab plus CyBorD

2024-7-29

Prognostic factors for chronic thrombocytopenia in systemic lupus erythematosus with immune thrombocytopenia

2024-7-29

Long-Term Follow-Up of Eltrombopag Treatment for Patients with Cyclosporin A Refractory/Relapsed Transfusion-Dependent Non-Severe Aplastic Anemia: A Report from a Single Center in China

2024-7-17

Factor VIII levels and ISTH DIC scores do not distinguish DIC from the coagulopathy of liver disease

2024-7-16

Enhanced Survival of Chronic Myelomonocytic Leukemia-Dysplastic over Proliferative Subtype after Allogeneic Hematopoietic Cell Transplant: A Tertiary Center Experience and Literature Review

2024-6-26

Effect of Digital Health Coaching on Self-Efficacy and Patient Reported Outcomes in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia: A Pilot Randomized Controlled Trial

2024-6-11

Pharmacokinetic-guided hydroxyurea to reduce transfusions in Ugandan children with sickle cell anemia: study design of the Alternative Dosing And Prevention of Transfusions (ADAPT) trial

2024-6-5

Safety of extended pirtobrutinib exposure in relapsed and/or refractory B-cell malignancies

2024-6-5

Biologic and clinical characteristics of isochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia

2024-5-31

TES and SLC40A1 as Potential Biomarkers for Predicting Survival in T-Cell Acute Lymphoblastic Leukemia

2024-5-28

Eosinophilic pleocytosis in the cerebrospinal fluid following CAR-T cell therapy for CNS lymphoma: A case for warning?

2024-5-24

Novel compound heterogeneous mutations in CYB5R3 gene leading to methemoglobinemia (type I) in a Chinese boy

2024-5-24

Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New Therapeutics

2024-5-22

Racial and ethnic characteristics and outcomes of patients diagnosed with CLL/SLL in the United States

2024-5-20

HLA-DRB5 overexpression promotes platelet reduction in immune thrombocytopenia mice model by facilitating MHC-II-mediated antigen presentation

2024-5-15

Real-World Risk of Severe Cytopenias in Multiple Myeloma Patients Sequentially Treated with Immunomodulatory Drugs

2024-5-10

Toxicity of CAR T-Cell Therapy for Multiple Myeloma

2024-5-8

Historical Perspective of High-Dose Therapy Followed by Autologous Stem Cell Transplantation in Multiple Myeloma

2024-5-6

Cytomegalovirus Reactivation During Elotuzumab Therapy in Patients with Multiple Myeloma

2024-4-24

Long-term efficacy and safety of damoctocog alfa pegol prophylaxis in patients with haemophilia A aged 12–<18 years at enrolment into PROTECT VIII

2024-4-23

A Hematoma in the Anterior Abdominal Muscle in a Woman Receiving Venlafaxine: A Literature Review of the Reports on Similar Cases

2024-4-17

Efficacy, Safety and Quality of Life of Pegcetacoplan in Japanese Patients With Paroxysmal Nocturnal Hemoglobinuria Treated Within the Phase 3 PEGASUS Trial

2024-4-17

Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma and Primary Plasma Cell Leukemia Defined by New Criteria

2024-4-16

Failure of treatment-free remission after a prolonged deep molecular response in patients with chronic myeloid leukemia

2024-4-4

Consensus-Based Expert Recommendations on the Management of Hemophilia A in the Gulf Region

2024-4-2

Long Non-coding RNA RP11-252C15.1 is a Potential Biomarker of Prognosis and Hallmark for Leukemogenesis in Children with B-cell Precursor Acute Lymphoblastic Leukemia

2024-3-25

Utility of echocardiogram in neutropenic patients with gram positive bacteremia – a retrospective study

2024-3-25

The ratio of serum urea nitrogen to albumin is a better predictor of OS in MM patients than urea nitrogen alone

2024-3-25

The IRE1α Endonuclease Plays a Dual Role in Regulating the XBP1/miRNA-34a Axis and PD-1 Expression within Natural Killer Cells in Hodgkin Lymphoma

2024-3-14

Efficacy of Preexposure Prophylaxis with Monoclonal Antibody Tixagevimab-Cilgavimab against Emerging SARS-CoV-2 Resistant Variants in Patients with Chronic Lymphocytic Leukemia

2024-3-12

The Effect of Mind-Body Intervention on Lymphocyte Doubling Time and Treatment-Free Survival in Treatment-Naïve Chronic Lymphocytic Leukemia Patients

2024-3-12

Peeling Back the Layers: Recurrent Talquetamab Skin Toxicity after Supportive Stem Cell Boost in Multiple Myeloma

2024-3-6

Primary Nodal Epstein-Barr Virus-Positive T-Cell/NK-Cell Lymphoma: Real-World Experience

2024-3-3

Venous thromboembolism prophylaxis in inflammatory bowel disease inpatients – Systematic review and meta-analysis

2024-3-1

Impacts of Posttransplant Cyclophosphamide Dose on Graft-versus-Leukemia Effects via HLA-B Leader in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation

2024-3-1

Impact of COVID-19 on Patients with Beta-Thalassemia <i>Major</i>: An Observational Study

2024-2-28

Erratum

2024-2-27

Zanubrutinib plus cytarabine in patients with refractory/relapsed primary central nervous system lymphoma

2024-2-26

Oncogenic MTOR Signaling Axis Compensates BTK Inhibition in a Chronic Lymphocytic Leukemia Patient with Richter Transformation: A Case Report and Review of the Literature

2024-2-24

Evaluating the Economic Burden of Acute Myeloid Leukemia in Canada

2024-2-21

Clinical Outcomes, Survival, and Predictors in Lower-Risk Myelodysplastic Syndrome Patients Treated with Cyclosporine A

2024-2-17

Congenital Hypodysfibrinogenemia due to γ326Cys→Tyr Mutation: Third Ever-Described Case Associated with Recurrent Venous Thrombosis and COVID Vaccine

2024-2-17